Skip to content
The Cancer History Project
HOME
ABOUT
THE CANCER HISTORY PROJECT
THE CANCER LETTER
EDITORIAL BOARD
SPONSORS
CONTRIBUTORS
TCL ARCHIVES
LATEST ARTICLES
Search for:
Search
ARCHIVES
CMS also decided to cover off-label uses of approved colorectal cancer drugs in clinical trials, and allowed broader use of PET scans.
This article is from
The Cancer Letter
archive.
Vol. 30 No. 42 | November 5, 2004
Download PDF
Visit The Full Archive
Related Articles
TCL Archive
Eight CCRU, 20 CCSP Applications Submitted, Quality Is ‘Heartening’
November 19, 1982
TCL Archive
SEER Expects To Lower Cancer Incidence Rates for Blacks by 3%
September 27, 2002
TCL Archive
Mammography Summit Planned For June In Milan.
March 1, 2002
TCL Archive
Oncology Faces Cuts In CMS Revamp Of Physician Payments Under Part B.
July 10, 2009
TCL Archive
Feinstein Introduces New Cancer Act; Groups Say Bill Flawed
March 15, 2002
TCL Archive
Conferess Ok $10.9 Bil. NIH Bidget, OAM to Get $3.5 Million
October 15, 1993